Global pharma major Merck, which formed a joint venture with Sun Pharma, said that it was open for more alliances/ partnerships with other Indian companies as part of the growth strategy for emerging markets and launch innovative new products. Cardiovascular diseases, diabetes, viral diseases, anti-infectives, and dermatology are among the areas in which Merck & Co, known as MSD in India and markets outside the U.S. and Canada, will seek to have alliances/ joint ventures to leverage its expertise, Kevin Ali, President, Emerging Markets, Merck, told The Hindu here on the sidelines of Bio-Asia 2012, which began here on Thursday.
